CN Patent

CN118680948B — 寡核苷酸及其在抗乙型肝炎病毒中的应用

Assigned to Sihegene Beijing Biotechnology Co ltd · Expires 2025-08-22 · 1y expired

What this patent protects

本发明涉及一种修饰的反义寡核苷酸或其盐及其在用于制备预防或治疗HBV相关疾病或症状的药物中的用途。修饰后的反义寡核苷酸在保持降低HBV表达效率的基础上，可以显著延长作用时间。

USPTO Abstract

本发明涉及一种修饰的反义寡核苷酸或其盐及其在用于制备预防或治疗HBV相关疾病或症状的药物中的用途。修饰后的反义寡核苷酸在保持降低HBV表达效率的基础上，可以显著延长作用时间。

Drugs covered by this patent

eplontersen-sodium (EPLONTERSEN SODIUM)

Patent Metadata

Patent number: CN118680948B
Jurisdiction: CN
Classification: —
Expires: 2025-08-22
Drug substance claim: No
Drug product claim: No
Assignee: Sihegene Beijing Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.